Skip to main
STAA

STAAR Surgical (STAA) Stock Forecast & Price Target

STAAR Surgical (STAA) Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 25%
Buy 13%
Hold 50%
Sell 0%
Strong Sell 13%

Bulls say

Staar Surgical is a promising company with strong fundamentals, evidenced by its steady revenue and profit growth, geographic diversification, and potential for future growth in the US and China markets. The company's expansion efforts, positive feedback from ophthalmologists, and new product launch further support a positive outlook on the stock. While there may be some risks to consider, overall the company appears to be on a positive trajectory in the coming years.

Bears say

Staar Surgical is a company with strong top and bottom line results, indicating a significant increase in demand for its products. The company's record Q1 net sales, strong performance in the US and a much stronger-than-expected China recovery all suggest positive momentum for the company. The company's use of biocompatible Collamer material has also helped it to establish itself as a global leader in the industry. However, it should be noted that almost all of the revenue is generated from foreign sales, making the company heavily reliant on external markets and susceptible to external economic and political factors.

STAAR Surgical (STAA) has been analyzed by 8 analysts, with a consensus rating of Hold. 25% of analysts recommend a Strong Buy, 13% recommend Buy, 50% suggest Holding, 0% advise Selling, and 13% predict a Strong Sell.

This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STAAR Surgical (STAA) Forecast

Analysts have given STAAR Surgical (STAA) a Hold based on their latest research and market trends.

According to 8 analysts, STAAR Surgical (STAA) has a Hold consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $28.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $28.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STAAR Surgical (STAA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.